14-08-2026 16:56 via drugs.com

Many With Atypical Alzheimer Disease Do Not Qualify for Anti-Amyloid Therapy

FRIDAY, Aug. 14, 2026-- Many people with atypical Alzheimer disease (AD) do not meet eligibility criteria for anti-amyloid therapies (AAT), according to a study published online Aug. 5 in Neurology.Dror Shir, M.D., from the Mayo Clinic in...
Read more »

Pharmaceutical Industry news



Burnout Common Among Psychiatric Mental Health Registered Nurses
FDA Approves First Self-Balancing, Personal Exoskeleton
Suboptimal Adherence to Brain Health Recommendations Common in Early Alzheimer Disease
Genomic Newborn Screening Could ID Cancer Predisposition Syndrome
Report Highlights Substance Use in Young Adults in U.S. in 2025
Imaging Turnaround Time Increased From 2023 to 2024
Stair Climbing Associated With Reduction in Cardiovascular, All-Cause Mortality
Socioeconomic Inequalities Tied to Functional Aging
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay
First Metatarsophalangeal Joint Arthrodesis Eases Painful Hallux Rigidus
Menopausal Hormone Therapy Use Linked to Lower Risk for Alzheimer Disease
Study IDs Neurobiological Roots of Sensory Over-Responsivity
2005 to 2023 Saw Decrease in DXA Testing for Osteoporosis Screening
Endometriosis Tied to Higher Risk for Developing Type 2 Diabetes
Desktop versie